Deep Pujara
@deeppujara
Followers
51
Following
203
Media
0
Statuses
83
Joined May 2010
Women Benefit Equally From Endovascular Thrombectomy for Large Core Ischemic Stroke in a Subanalysis of SELECT2 In this #BloggingStroke post, @drchloemutimer discusses #Stroke article by @JPTsaiMD et al. #AHAJournals #GoRedForWomen
https://t.co/uzXXexw67m
1
11
13
Congratulations to @JPTsaiMD on leading the analysis on sex-based differences in EVT outcomes for large strokes from @SELECT2Trial, published in @StrokeAHA_ASA's #GoRedforWomen collection. No significant heterogeneity in EVT benefits across sexes. Age and ischemic core size
#STROKE: In a post hoc analysis of the SELECT-2 trial, both biological sexes enjoyed equal benefit from EVT in the setting of established large core infarction. #AHAJournals #GoRedforWomen
https://t.co/MSDzAQunBg
0
9
28
.@UHhospitals has been awarded US$7 million in research funding by @PCORI to evaluate endovascular #Thrombectomy in patients presenting more than 24 hours from time last known well via the global SELECT LATE clinical trial @amrsarrajMD @SELECT2Trial
https://t.co/IPobwZKCsO
neuronewsinternational.com
University Hospitals (UH) Cleveland Medical Center in Cleveland, USA has been awarded US$7 million in research funding by the Patient-Centered Outcomes Research Institute (PCORI) to evaluate endova...
0
7
24
Honored and grateful for the opportunity to assess the role of Endovascular Thrombectomy beyond 24 hours of last known well through SELECT LATE international, multicenter pragmatic clinical trial - https://t.co/XiCsnwdnEC funded by @PCORI @UHhospitals Excited to collaborate
pcori.org
1
15
54
Congratulations @AmeerEHassan @Michael3Abraham on leading analyses on effect of procedure characteristics and reperfusion success on EVT outcomes for patients with large strokes from @SELECT2Trial
https://t.co/UGALEbs3u0
@ANA_journals ~80% procedural success that improved
0
16
49
Our comprehensive review @ANA_journals on current neuroimaging evidence for reperfusion therapies, shifting treatment paradigms and utility of different imaging modalities in acute ischemic stroke. @DrBruceCampbell @deeppujara
https://t.co/4W75wPtPOE
onlinelibrary.wiley.com
Stroke is the chief differential diagnosis in patient presenting to the emergency room with abrupt onset focal neurological deficits. Neuroimaging, including non-contrast computed tomography (CT),...
0
11
42
Honored to receive the 2024 Clinical Research Forum top 10 award on behalf of @SELECT2Trial investigators.Inspiring & motivational to see exciting progress on many healthcare fronts by elite clinician scientists.This recognition motivates us to keep pushing boundaries @CRForumUS
18
10
75
🎯 Major Findings in Stroke 🌟 Hopeful twist in recovery! Despite 75% patients experience intracranial hemorrhage post-EVT, functional outcomes remain unaffected. 🧠💪 SELECT2 trial shows hemorrhages are not the end of the road! 🚀 Read the full study 👉 https://t.co/ppyu1myLaI
0
20
57
Proud and honored to present @SELECT2Trial results at #ISC2023 EVT is safe and efficacious in large core! We’re a step closer to improving more patients lives.
nejm.org
Trials of the efficacy and safety of endovascular thrombectomy in patients with large ischemic strokes have been carried out in limited populations. We performed a prospective, randomized, open-lab...
17
85
308
Our latest @JAMANeuro “SELECT Late” international cohort study; EVT was associated with increased odds of functional independence in selected patients treated beyond 24 hours of last known well #NoLVOleftbehind #stroke #neurology
jamanetwork.com
This cohort study analyzes data for patients who were treated beyond 24 hours after they were last known well to determine functional and safety outcomes for endovascular thrombectomy vs best medical...
1
22
91
We’ve made it to 800 followers. Be apart if the conversation by sharing and commenting on ACTN and Annals of Neurology publications on Twitter. Help us make it to 1000 followers. Tag a friend who shouldn’t miss out! @TheNewANA1 @AANmember.
0
1
2
Hello #NeuroTwitter Join us in welcoming our awesome residency program director, @DCPneuro to the world of #Twitter 🥳 It took a long time convincing him, so show him some love 🧠❤️ #NeurologyProud @AANEMorg @AANMember #Neurology #Residency @NMatch2023
4
4
28
I sit with the legendary @jimgrotta to discuss #BEST-MSU. MSU 🚑 provides faster thrombolysis, enhances #stroke outcomes, shortens time to EVT and is cost-effective. This world renowned strokologist, and my mentor, is a great listen. Like an old wine, only gets better with age!
Amrou Sarraj, MD, interviews James Grotta, MD, on the trial design & execution of the recently published BEST-MSU clinical trial analyzing the benefit of prehospital stroke treatment delivered through a mobile stroke unit. @amrsarrajMD #neurotwitter
0
3
14
https://t.co/dUGuknZTXu Our #latest meta-analysis+review on direct carotid access when it is absolutely necessary to go north & giving up is not an option!#GTFVO #NeverBackDown @visishs @almuftifawaz @KunalVakhariaMD @amrsarrajMD @svinsociety @AmeerEHassan @elghanemmoh
"Carotid sticking it to all the doubters." - @Eric_Feldstein Huge thank you to this team for their work demonstrating the feasibility and safety of alternative transcarotid access when femoral and radial access are impractical. @almuftifawaz @NeurologyNymc @nymcbrainspine
1
8
21
Latest content - https://t.co/lC2ZL32MvZ - Fifi et al. found women had similar discharge outcomes as men following #EVT, but the improvement from discharge to 90 days was significantly worse in women. @johannatfifi @Faris_Shaker @amrsarrajMD @StavTjoumakaris @AnneAlexandrov
0
5
13
❗Late breaking oral abstracts happening now #ISC22❗ Update on this trial: SELECT2 seeks to evaluate thrombectomy in patients with large core on perfusion imaging 👏 Interim analysis showed no safety concerns and will continue enrollment 👏 @amrsarrajMD
0
7
18
…time & start focusing on salvageable tissue w disabling deficits as primary indication for MT. More data presented today #ISC22 showing benefit of MT >24hrs by @amrsarrajMD. More data coming…@GhadaMohamedMD @aboulnourh @OwaisAlsrouji @HenryFordNeuro @AshuPJadhav @stephanamayer
0
3
16
Our new paper continuing with meningeal theme. #MMA embo for #SDH especially patients needing DAPT or AC is safe and effective no recurrence. @eytanraz @omar_tanweer @neuroangio1 @NeuroUnited @hariskamalmd
3
17
48
More than 14 months of hard work finally got published in @CureusInc . many thanks to @deeppujara @NPrashantra for your perseverance. #NeuroTwitter #neurocovid #MedTwitter
1
4
10
Pleasure speaking @esmintsociety #ESMINT2021 on EVT in LVO/mild deficits. Immediate EVT vs rescue. How to identify potential neurology worsening (clot location, collaterals/perfusion, clot burden). Nothing like a LIVE talk at 2 AM😉@ESOstroke @WorldStrokeEd @marcriboj
EVT in minor stroke with LVO??? Good answers from @amrsarrajMD @esmintsociety @ESOstroke @SNISinfo @GuenegoAdrien #esmint2021
2
3
33